Silica vs Silicone: Key Differences in Structure, Properties and Uses

Published: Source: Silica Raw Materials News Section: Silica Raw Materials

📌 Key Takeaways

  • Topic: Silica Market Trends 2026: Demand Drivers, Technologies and Regional Outlook
  • Keywords: matting agent for coatings
  • Published: 2026-11-20 02:50:32
  • Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Ho et al. employed the Multiple-Path Particle Dosimetry (MPPD) model for aerosolization and determination of lung deposition of silver nanoparticles, which method may be broadened to other materials like mesoporous silica nanoparticles [ 87 ]. It suggests particle size (mean 18 nm), density, and generation approach as principal elements that determine aerosolization efficiency and inhaled dose. Simulations of airflow, diffusion, sedimentation, and impact through airway generations yield comparable alveolar deposition fractions for particles less than 100 nm in humans and rats. With the addition of species-specific parameters, such as respiratory rate, lung surface region, tidal volume, and finished with possible lobar- and airway-level analysis, the MPPD model makes realistic regional retention predictions. Given that mesoporous silica nanoparticles are of similar size and physicochemical properties, the same methodology can estimate their aerosolization and lung deposition. In summary, the MPPD model is a handy tool in the assessment of inhalation danger and in guiding the formulation of safer nanomaterials [ 87 ]. In another study, Ali et al. applied the MPPD model to simulate aerosolization and lung deposition of mesoporous silica nanoparticles [ 88 ]. Pre-characterized MSNs with pre-specified aerodynamic diameters were initially assessed through scanning mobility particle sizing to yield accurate size-distribution inputs. Asymmetric mouse airway geometry and physiological parameters such as respiratory rate, lung volume, and airflow were used in simulations that were approximated to provide a total lung deposition of about 45%, of which 37% was in the head, 27% in the tracheobronchial, and 36% in the pulmonary (alveolar) region. These predictions are in reasonable agreement with earlier in vivo findings, validating the model. MPPD analysis also indicated that smaller MSNs exhibit more alveolar deposition, with the larger particles being better in the upper airways. Through linking aerosolization efficiency (via size distribution and concentration) and regional deposition, this modeling approach orients optimization of nanoparticle size and generation techniques toward maximizing targeted lung delivery [ 88 ]. To achieve easier production of aerosols, the surface of nanoparticles is often provided with a polymer coating, thereby stabilizing their distribution and increasing dispersibility [ 56 ]. By lowering the particle size, deeper lung areas can be reached [ 25 ]. Particles smaller than 1 µm are capable of accumulating in the alveoli, but the ideal size range to achieve maximum efficiency is in the 200-500 nm range [ 25 ]. Nevertheless, another review cited that particle size in the range of 50-200 nm is ideal for maximizing drug localization by inhalation [ 89 ]. It has also been recommended that the perfect diameter is approximately 500 nm for phagocytosis by alveolar macrophages [ 89 ]. Li et al. nebulized PEI-PEG-coated MSNs (50 nm particle size) by standard nebulizers without compromising their structure, while keeping particles in their individual form within the water droplets [ 90 ]. The aerosol supplies convenient delivery of MSNs to all areas of the respiratory tract - nasal, tracheobronchial, and pulmonary - and they persist for a week following inhalation, mostly within alveolar macrophages. It offers intracellular targeted delivery of lung diseases without passing through the gastrointestinal and first-pass metabolism. In spite of decreased deep lung deposition in mice under nasal breathing, exposure is comparable to that of humans with inhalation. Toxicity tests revealed no tissue damage or inflammation, further supporting MSN inhalation as a safe and effective method for vast treatment of pulmonary diseases, feasible for clinical translation [ 90 ]. A study investigated the effect of surface chemistry on drug loading capacity, release kinetics, and antibiotic activity in pulmonary infections on S. aureus bacterial cultures [ 18 ]. The model drugs were isoniazid, rifampicin, and vancomycin. Remarkable absorption ability was observed only with thiol (-SH) grafted carriers for all the tested drugs [ 18 ]. The in vitro drug release study showed sustained, but limited release: the cumulative release of rifampicin was 78.5% after 12 days, estimated by antibiogram [ 18 ]. Interestingly, the MIC values of the MSN-drug complex were higher for the free drug, probably due to the delayed and incomplete release from the pores [ 18 ]. Wang et al. developed a polydopamine-coated MSN formulation co-loaded with Ziyuglycoside I and Oseltamivir for the treatment of viral pneumonia. Interestingly, in vitro and in vivo studies have demonstrated that this carrier provided immediate release of Oseltamivir (allows quick virus killing) but prolonged release of Ziyuglycoside I (cuts down the inflammatory response for a longer period) [ 62 ].

What Is Synthetic Amorphous Silica (SAS)? Types, Safety and Regulatory Status

Fumed Silica Alternatives: Cost-Effective Substitutes and How They Compare
Got 2025 Aug 17; Revised 2025 Sep 15; Accepted 2025 Sep 15; Collection date 2025 Sep.
Silica for Wafer Polishing: Slurry Types, Particle Size and Performance
Cab-O-Sil M-5: Specifications, Uses and Equivalent Fumed Silica Grades
The physicochemical characteristics of SNPs have a substantial impact on pharmacokinetics, thus influencing distribution, accumulation in various cells, degradation, and elimination from the body [ 1, 10 ]. It is also known that the particle size, particle morphology, pore structure, and surface properties are mainly to blame for possible toxicity, so ultimately also for the effectiveness of the therapy [ 10 ]. Additionally, the adsorption of molecules into the pores can also be influenced by tailoring these properties [ 1, 12 ]. The parameters of the particles can be changed within a wide range and can be customized according to the wishes [ 10, 12 ]. The conditions of the synthesis can exactly tune and reproduce the particle size, particle shape, or pore structure, which can make drug formulation and therapy more effective [ 1, 10 ]. Understanding the physicochemical properties of nanoparticles is key to achieve more effective treatment. The most important articles covered in this section are included in Table 1.
Microsilica for Cement: Benefits, Dosage Guidelines and Applications

Silica for Chromatography: Particle Size, Pore Size and Grade Selection

What is silica (SiO₂)?

silica for tires 57. Narayan R., Nayak U.Y., Raichur A.M., Garg S. Mesoporous silica nanoparticles: A comprehensive review on synthesis and recent advances. Pharmaceutics. 2018;10:118. doi: 10.3390/pharmaceutics10030118. [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ]

What is the difference between fumed silica and precipitated silica?

silicon oxide anode 32. Voicu S.N.P., Dinu D., Sima C., Hermenean A., Ardelean A., Codrici E., Stan M.S., Zărnescu O., Dinischiotu A. Silica nanoparticles induce oxidative stress and autophagy but not apoptosis in the MRC-5 cell line. Int. J. Mol. Sci. 2015;16:29398-29416. doi: 10.3390/ijms161226171. [ DOI ] [ PMC free piece ] [ PubMed ] [ Google Scholar ]

What drives silica raw material prices?

fumed silica vs precipitated silica 53. Kramarczyk D., Knapik-Kowalczuk J., Smolka W., Monteiro M.F., Tajber L., Paluch M. Inhibition of celecoxib crystallization by mesoporous silica - Molecular dynamics studies leading to the discovery of the stabilization origin. Eur. J. Pharm. Sci. 2022;171:106132. doi: 10.1016/j.ejps.2022.106132. [ DOI ] [ PubMed ] [ Google Scholar ]

Cite this article: Silica Raw Materials News. "Silica vs Quartz: Are They the Same? Differences Explained ." Published 2026-11-20 02:50:32. /news/article.html
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.